- Delivering Pan India
Histoglob® (Histamine + Human Normal Immunoglobulin) Histamine 0.15 mcg + Human Normal Immunoglobulin 12 mg per 1 mL 1 ml vial by Bharat Serums and Vaccines. Genuine stock supplied in bulk/wholesale quantities to hospitals and pharmacies across India by A.K. Pharma, a licensed pharmaceutical distributor in Delhi.
| Composition | Histamine 0.15 mcg + Human Normal Immunoglobulin 12 mg per 1 mL |
|---|---|
| Manufacturer | Bharat Serums and Vaccines |
| Country | India |
| Pack size | Histamine 0.15 mcg + Human Normal Immunoglobulin 12 mg per 1 mL: Pack of 3 vials (as listed on our product page) |
| Storage | Store refrigerated at 2°C to 8°C. Do not freeze. |
Supplied only against a valid prescription from a registered medical practitioner.
Sourced from authorised channels
Temperature-controlled packing
Hospitals, clinics, pharmacies
Delhi drug licence holder
Histoglob® (Histamine + Human Normal Immunoglobulin) Histamine 0.15 mcg + Human Normal Immunoglobulin 12 mg per 1 mL 1 mL vial — Histamine and Human Normal Immunoglobulin Injection 1 mL: A Sourcing Guide for Hospitals and Pharmacies
Histoglob® is a histamine and human normal immunoglobulin combination injection for subcutaneous use, marketed in India by Bharat Serums and Vaccines Limited (BSV). The decision to prescribe histamine + human normal immunoglobulin, including patient selection, dose and monitoring, rests entirely with the treating physician. This page provides sourcing and procurement information for hospitals and pharmacies, not clinical or treatment guidance.
As both a trusted medicine distributor in Delhi and a licensed pharmaceutical distributor in Delhi, A.K. Pharma supplies genuine Histoglob® (histamine + human normal immunoglobulin) Histamine 0.15 mcg + Human Normal Immunoglobulin 12 mg per 1 mL 1 ml vial to hospitals and pharmacies across India. Buyers comparing pharmaceutical distribution companies and wholesale pharmaceutical distributors can also browse our full product range and the cancer medicines category. Supply is in bulk/wholesale quantities only.
Histoglob is a 1 mL single-dose vial containing histamine (0.15 mcg), human normal immunoglobulin (12 mg) and sodium thiosulphate (32 mg), as listed on the manufacturer’s pack and pharmacy listings. It is manufactured in India by Bharat Serums and Vaccines Limited and is for subcutaneous injection only.
How it works, according to the label: Product literature describes the preparation as a histamine–immunoglobulin complex (histaglobulin) intended to stimulate the body’s own anti-histamine antibody activity. The exact approved indications, schedule and precautions are those printed on the pack insert.
The current US prescribing information for the manufacturer’s pack insert and published histaglobin literature (DailyMed) lists the following. Indications in India may differ and are defined by the Indian regulator and the Histoglob pack insert.
Published literature on histamine–immunoglobulin complexes (histaglobin) in allergic conditions includes small and older studies, for example a 1964 report in the journal Allergy on histaglobin treatment of allergic conditions in children and a 1977 clinical report in allergic rhinitis, plus a recent systematic review. These publications are listed in the Sources section; evidence quality and conclusions are those of the authors, and A.K. Pharma does not interpret them.
| Strength | Dosage form | Pack size (as shown on the carton) |
|---|---|---|
| Histamine 0.15 mcg + Human Normal Immunoglobulin 12 mg per 1 mL | Injection (subcutaneous), vial | Pack of 3 vials (as listed on our product page) |
Please confirm the current pack and batch with us before ordering. Dose and regimen must be determined and followed exactly as directed by the treating physician and the approved prescribing information.
Hospitals, clinics and pharmacies in India that need to source Histoglob in bulk quantities from a licensed distributor.
Side effects are described in the manufacturer’s pack insert and are not summarised here. As with immunoglobulin-containing injections, local injection-site reactions and hypersensitivity are among the reactions generally reported; consult the insert and your physician.
All use should follow the approved prescribing information and the instructions of the treating physician.
Store refrigerated at 2°C to 8°C. Do not freeze. Protect from light and follow the storage instructions on the carton.
Histoglob is marketed by Bharat Serums and Vaccines. A.K. Pharma is a licensed distributor and does not manufacture the product. As one of the pharmaceutical distributors serving Indian hospitals, we source Histoglob through authorised channels and supply it with pack and batch details. Buyers comparing a pharmaceutical wholesale distributors list or a pharma distribution company can verify our credentials on the About Us page.
Is Histoglob available in India?
A.K. Pharma supplies Histoglob (histamine + human normal immunoglobulin) Histamine 0.15 mcg + Human Normal Immunoglobulin 12 mg per 1 mL 1 ml vial to hospitals and pharmacies in India. Contact us for current availability.
What does Histoglob contain?
Histoglob is a 1 mL injection containing histamine and human normal immunoglobulin, marketed by Bharat Serums and Vaccines Limited in India.
Can I order a single pack?
A.K. Pharma is a distributor and supplies bulk/wholesale quantities only, not one or two pieces.
How should Histoglob be stored?
The manufacturer’s listing advises refrigeration at 2°C to 8°C without freezing.
Does A.K. Pharma advise on dosing or suitability?
No. Treatment decisions, including dosing, rest solely with the treating physician and the approved prescribing information.
How do I request a quote?
Call or WhatsApp us, or use the contact details below.
📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052
📞 011 4172 6999
📱 WhatsApp: +91 9810034827
🌐 akpharma.in
Disclaimer: This page is intended for informational and sourcing/procurement purposes only and does not constitute medical or clinical advice. A.K. Pharma is a licensed medicine distributor, not a healthcare provider, and does not provide clinical guidance. All treatment decisions, including drug selection and dosing, rest solely with the treating physician and should follow the approved prescribing information.
